Breast Cancer clinical trials
Showing 601–650 of 1,067 active trials. Describe your situation to see which ones you may be eligible for.
- PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
- HER2-positive Breast Cancer Registry
- Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision
- Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
- QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
- Identifying Patterns in the Breath of Individuals With Breast Cancer
- AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction
- EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
- Individuals on Hormone Therapy Breast Cancer Screening Pilot
- Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
- A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)
- A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
- WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
- CtDNA Based MRD Testing for NAC Monitoring in TNBC
- Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
- Surveillance MRI Registry for Patients Who Had Breast Cancer With Dense Breast Tissue
- Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
- COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
- Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
- Breast Cancer Survivorship Biorepository
- Quantitative MRI Assessment of Breast Cancer Therapy Response
- Susan G. Komen's ShareForCures
- Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
- Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
- TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
- Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
- A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania
- Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
- Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
- Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis
- Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway
- De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
- CTNNA1 Familial Expansion Study
- Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
- Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
- Intra-Operative Radiation Registry
- Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
- Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer
- Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
- Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer
- Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
- Brain Health in Breast Cancer Survivors
- Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
- Prospective Breast Cancer Biospecimen Collection
- Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- GammaPod Registry and Quality of Life Nomogram
- Older Breast Cancer Patients: Risk for Cognitive Decline
- Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.